Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway

Food and Chemical Toxicology

Volumn 62, Issue , 2013, Pages 892-900

  Zuo, Li ^a   Lu, Man ^a   Zhou, Qing ^a   Wei, Wei ^a   Wang, Yuan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Butyrate; Colorectal cancer; Endocan; Lentivirus; MAPK; ShRNA

Indexed keywords

BUTYRIC ACID; ENDOCAN; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEOGLYCAN; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; ESM1 PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INHIBITION KINETICS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; COLONIC NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS); LENTIVIRUS;

BUTYRATES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEOGLYCANS;

EID: 84887564603     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.10.028     Document Type: Article

References (43)

1. Assefa Z., Vantieghem A., Garmyn M., Declercq W., Vandenabeele P., Van-denheede J.R., Bouillon R., Merlevede W., Agostinis P. P38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mito-chondrial cytochrome c release in ultraviolet B radiation-induced apoptosis. J. Biol. Chem. 2000, 275:21416-21421.
2. Barrasa J.I., Santiago-Gómez A., Olmo N., Lizarbe M.A., Turnay J. Resistance to butyrate impairs bile acid-induced apoptosis in human colon adenocarcinoma cells via up-regulation of Bcl-2 and inactivation of Bax. Biochim. Biophys. Acta. 2012, 1823:2201-2209.
3. Béchard D., Gentina T., Delehedde M., Scherpereel A., Lyon M., Aumercier M., Vazeux R., Richet C., Degand P., Jude B., Janin A., Fernig D.G., Tonnel A.B., Lassalle P. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J. Biol. Chem. 2001, 276:48341-48349.
4. Blouin J.M., Penot G., Collinet M., Nacfer M., Forest C., Laurent-Puig P., Coumoul X., Barouki R., Benelli C., Bortoli S. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex. Int. J. Cancer 2010, 128:2591-2601.
5. Cao X.H., Wang A.H., Wang C.I., Mao D.Z., Lu M.F., Cui Y.Q., Jiao R.Z. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Chem. Biol. Interact. 2008, 183:357-362.
6. Carrillo L.M., Arciniegas E., Rojas H., Ramírez R. Immunolocalization of endocan during the endothelial-mesenchymal transition process. Eur. J. Histochem. 2011, 55:e13.
7. Chen L.Y., Liu X., Wang S.L., Qin C.Y. Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J. Int. Med. Res. 2010, 38:498-510.
8. Clarke J.M., Young G.P., Topping D.L., Bird A.R., Cobiac L., Scherer B.L., Winkler J.G., Lockett T.J. Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats. Carcinogenesis 2011, 33:197-202.
9. Domokos M., Jakus J., Szeker K., Csizinszky R., Csiko G., Neogrady Z., Csordas A., Galfi P. Butyrate-induced cell death and differentiation are associated with distinct patterns of ROS in HT29-derived human colon cancer cells. Dig. Dis. Sci. 2010, 55:920-930.
10. Doyle W., Shide E., Thapa S., Chandrasekaran V. The effects of energy beverages on cultured cells. Food. Chem. Toxicol. 2012, 50:3759-3768.
11. Fleury C., Mignotte B., Vayssière J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002, 84:131-141.
12. Fronza M., Heinzmann B., Hamburger M., Laufer S., Merfort I. Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts. J. Ethnopharmacol. 2009, 126:463-467.
13. Fung K.Y., Cosgrove L., Lockett T., Head R., Topping D.L. A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br. J. Nutr. 2012, 108:820-831.
14. Fung K.Y., Ooi C.C., Lewanowitsch T., Tan S., Tan H.T., Lim T.K., Lin Q., Williams D.B., Lockett T.J., Cosgrove L.J., Chung M.C., Head R.J. Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells. J. Proteome. Res. 2012, 11:6019-6029.
15. Hatfield K.J., Lassalle P., Leiva R.A., Lindås R., Wendelboe Ø., Bruserud Ø. Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia. Hematology 2011, 16:351-356.
16. Hovhannisyan G., Aroutiounian R., Glei M. Butyrate reduces the frequency of micronuclei in human colon carcinoma cells in vitro. Toxicol. In Vitro 2009, 23:1028-1033.
17. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics. CA. Cancer J. Clin. 2008, 58:71-96.
18. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathwaysmediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
19. Lassalle P., Molet S., Janin A., Heyden J.V., Tavernier J., Fiers W., Devos R., Tonnel A.B. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J. Biol. Chem. 1996, 271:20458-20464.
20. Leonel A.J., Alvarez-Leite J.I. Butyrate: implications for intestinal function. Curr. Opin. Clin. Nutr. Metab. Care. 2012, 15:474-479.
21. Leroy X., Aubert S., Zini L., Franquet H., Kervoaze G., Villers A., Delehedde M., Copin M.C., Lassalle P. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 2010, 56:180-187.
22. Liu L., Li L., Min J., Wang J., Wu H., Zeng Y., Chen S., Chu Z. Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell. Immunol. 2012, 277:66-73.
23. Martínez-Osorio H., Calonge M., Corell A., Reinoso R., López A., Fernández I., SanJosé E.G., Diebold Y. Characterization and short-term culture of cells recovered from human conjunctival epithelium by minimally invasive means. Mol. Vis. 2009, 15:2185-2195.
24. Matthews G.M., Howarth G.S., Butler R.N. Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism. Chemotherapy 2012, 58:102-109.
25. Maurage C.A., Adam E., Minéo J.F., Sarrazin S., Debunne M., Siminski R.M., Baroncini M., Lassalle P., Blond S., Delehedde M. Endocan expression and localization in human glioblastomas. J. Neuropathol. Exp. Neurol. 2009, 68:633-641.
26. Myung D.S., Park Y.L., Chung C.Y., Park H.C., Kim J.S., Cho S.B., Lee W.S., Lee K.H., Lee J.H., Joo Y.E. Expression of livin in colorectal cancer and its relationship to tumor cell behavior and prognosis. PLoS ONE 2013, 8:e73262.
27. Rennel E., Mellberg S., Dimberg A., Petersson L., Botling J., Ameur A., Westholm J.O., Komorowski J., Lassalle P., Cross M.J., Gerwins P. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp. Cell. Res. 2007, 313:1285-1294.
28. Roudnicky F., Poyet C., Wild P., Krampitz S., Negrini F., Huggenberger R., Rogler A., Stöhr R., Hartmann A., Provenzano M., Otto V.I., Detmar M. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2013, (Epub ahead of print).
29. Sarrazin S., Adam E., Lyon M., Depontieu F., Motte V., Landolfi C., Lortat-Jacob H., Bechard D., Lassalle P., Delehedde M. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim. Biophys. Acta. 2005, 1765:25-37.
30. Scheppach W., Weiler F. The butyrate story: old wine in new bottles?. Curr. Opin. Clin. Nutr. Metab. Care. 2004, 7:563-567.
31. Shen H.M., Liu Z.G. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 2006, 40:928-939.
32. Slattery M.L., Curtin K., Anderson K., Ma K.N., Ballard L., Edwards S., Schaffer D., Potter J., Leppert M., Samowitz W.S. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J. Natl. Cancer Inst. 2000, 92:1831-1836.
33. Suzuki T., Yoshida S., Hara H. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr. 2008, 100:297-305.
34. Tavakkol-Afshari J., Brook A., Mousavi S.H. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food. Chem. Toxicol. 2008, 46:3443-3447.
35. Thangaraju M., Cresci G.A., Liu K., Ananth S., Gnanaprakasam J.P., Browning D.D., Mellinger J.D., Smith S.B., Digby G.J., Lambert N.A., Prasad P.D., Ganapathy V. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009, 69:2826-2832.
36. Tsai J.C., Zhang J., Minami T., Voland C., Zhao S., Yi X., Lassalle P., Oettgen P., Aird W.C. Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter. Vasc. Res. 2002, 39:148-159.
37. Wang L., Luo H.S., Xia H.J. Sodium butyrate induces human colon carcinoma HT-29 cell apoptosis through a mitochondrial pathway. Int. Med. Res. 2009, 7:803-811.
38. Wang H., An H., Wang B., Liao Q., Li W., Jin X., Cui S., Zhang Y., Ding Y., Zhao L. miR-133a Represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Eur. J. Cancer 2013.
39. Zhang Y., Zhou L., Bao Y.L., Wu Y., Yu C.L., Huang Y.X., Sun Y., Zheng L.H., Li Y.X. Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem. Biol. Interact. 2010, 185:174-181.
40. Zhang S., Bai J., Ren S., Wang R., Zhang L., Zuo Y. Sodium butyrate restores ASC expression and induces apoptosis in LS174T cells. Int. J. Mol. Med. 2012, 30:1431-1437.
41. Zhang S., Zuo L., Gui S., Zhou Q., Wei W., Wang Y. Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin. Mol. Biol Rep. 2012, 39:2843-2849.
42. Zimmerman M.A., Singh N., Martin P.M., Thangaraju M., Ganapathy V., Waller J.L., Shi H., Robertson K.D., Munn D.H., Liu K. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2012.
43. Zuo L., Zhang S.M., Hu R.L., Zhu H.Q., Zhou Q., Gui S.Y., Wu Q., Wang Y. Correlation between expression and differentiation of endocan in colorectal cancer. World J. Gastroenterol. 2008, 14:4562-4568.